SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form REGDEX - Notice of Sale of Securities [Regulation D and Section 4(6) of the Securities Act of 1933]:
SEC Accession No. 9999999997-05-050219
Filing Date
2005-12-20
Accepted
2005-12-27 15:27:03
Documents
1
Effectiveness Date
2005-12-20
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 AUTO-GENERATED PAPER DOCUMENT 9999999997-05-050219.paper REGDEX 293
  Scanned paper document scanned.pdf   301416
  Complete submission text file 9999999997-05-050219.txt   1761
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: REGDEX | Act: 34 | File No.: 021-56003 | Film No.: 05072358
SIC: 2834 Pharmaceutical Preparations